SUMATRIPTAN INJECTION DIN 02330571
Status: Cancelled Pre Market
Holder: TEVA CANADA LIMITED
Molecule: SUMATRIPTAN (SUMATRIPTAN SUCCINATE)
Health Canada record
| Active ingredient(s) | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 12 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N02CC01 SUMATRIPTAN |
| Original market date | |
| Current status date | 29-Jul-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SUMATRIPTAN (SUMATRIPTAN SUCCINATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02268388 | APO-SUMATRIPTAN | APOTEX INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Marketed |
| 02282313 | APO-SUMATRIPTAN | APOTEX INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Approved |
| 02268396 | APO-SUMATRIPTAN | APOTEX INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Marketed |
| 02212188 | IMITREX | GLAXOSMITHKLINE INC | Solution | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 6 MG | Marketed |
| 02212161 | IMITREX DF - TAB 100MG | GLAXOSMITHKLINE INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Marketed |
| 02268914 | MYLAN-SUMATRIPTAN | MYLAN PHARMACEUTICALS ULC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Marketed |
| 02268906 | MYLAN-SUMATRIPTAN | MYLAN PHARMACEUTICALS ULC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Marketed |
| 02268922 | MYLAN-SUMATRIPTAN | MYLAN PHARMACEUTICALS ULC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Marketed |
| 02256428 | PMS-SUMATRIPTAN | PHARMASCIENCE INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Marketed |
| 02256436 | PMS-SUMATRIPTAN | PHARMASCIENCE INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Marketed |
| 02256444 | PMS-SUMATRIPTAN | PHARMASCIENCE INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Marketed |
| 02286521 | SUMATRIPTAN | SANIS HEALTH INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Marketed |
| 02286548 | SUMATRIPTAN | SANIS HEALTH INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Marketed |
| 02385589 | SUMATRIPTAN DF | SIVEM PHARMACEUTICALS ULC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Marketed |
| 02385562 | SUMATRIPTAN DF | SIVEM PHARMACEUTICALS ULC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Approved |
| 02385570 | SUMATRIPTAN DF | SIVEM PHARMACEUTICALS ULC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Marketed |
| 02361698 | TARO-SUMATRIPTAN | TARO PHARMACEUTICALS INC | Solution | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 6 MG | Marketed |
| 02239367 | TEVA-SUMATRIPTAN | TEVA CANADA LIMITED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Marketed |
| 02286823 | TEVA-SUMATRIPTAN DF | TEVA CANADA LIMITED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Marketed |
| 02286815 | TEVA-SUMATRIPTAN DF | TEVA CANADA LIMITED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Marketed |
| 02286831 | TEVA-SUMATRIPTAN DF | TEVA CANADA LIMITED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Marketed |
| 02257904 | ACT SUMATRIPTAN | TEVA CANADA LIMITED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Post Market |
| 02257882 | ACT SUMATRIPTAN | ACTAVIS PHARMA COMPANY | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled Post Market |
| 02257890 | ACT SUMATRIPTAN | ACTAVIS PHARMA COMPANY | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Post Market |
| 02366258 | AVA-SUMATRIPTAN | AVANSTRA INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Post Market |
| 02366266 | AVA-SUMATRIPTAN | AVANSTRA INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Post Market |
| 02361515 | AVA-SUMATRIPTAN DF | AVANSTRA INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled (Unreturned Annual) |
| 02361507 | AVA-SUMATRIPTAN DF | AVANSTRA INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled (Unreturned Annual) |
| 02361523 | AVA-SUMATRIPTAN DF | AVANSTRA INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled (Unreturned Annual) |
| 02270749 | DOM-SUMATRIPTAN | DOMINION PHARMACAL | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled Post Market |
| 02270765 | DOM-SUMATRIPTAN | DOMINION PHARMACAL | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Post Market |
| 02270757 | DOM-SUMATRIPTAN | DOMINION PHARMACAL | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Post Market |
| 02163764 | IMITREX - TAB 50MG | GLAXO CANADA INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Post Market |
| 02212153 | IMITREX DF | GLAXOSMITHKLINE INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Post Market |
| 02239738 | IMITREX DF - TAB 25MG | GLAXOSMITHKLINE INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled Post Market |
| 01950606 | IMITREX INJ 12MG/ML | GLAXO CANADA INC | Liquid | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 12 MG | Cancelled Post Market |
| 01950614 | IMITREX TAB 100MG | GLAXO CANADA INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Post Market |
| 02358735 | NTP-SUMATRIPTAN DF | TEVA CANADA LIMITED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Pre Market |
| 02358727 | NTP-SUMATRIPTAN DF | TEVA CANADA LIMITED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Pre Market |
| 02358719 | NTP-SUMATRIPTAN DF | TEVA CANADA LIMITED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled Pre Market |
| 02336057 | NU-SUMATRIPTAN | NU-PHARM INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled (Unreturned Annual) |
| 02336065 | NU-SUMATRIPTAN | NU-PHARM INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled (Unreturned Annual) |
| 02336049 | NU-SUMATRIPTAN | NU-PHARM INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled (Unreturned Annual) |
| 02270714 | PHL-SUMATRIPTAN | PHARMEL INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled Post Market |
| 02270730 | PHL-SUMATRIPTAN | PHARMEL INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Post Market |
| 02270722 | PHL-SUMATRIPTAN | PHARMEL INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Post Market |
| 02375206 | Q-SUMATRIPTAN | QD PHARMACEUTICALS ULC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Pre Market |
| 02375192 | Q-SUMATRIPTAN | QD PHARMACEUTICALS ULC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Pre Market |
| 02375184 | Q-SUMATRIPTAN | QD PHARMACEUTICALS ULC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled Pre Market |
| 02271591 | RATIO-SUMATRIPTAN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Post Market |
| 02271583 | RATIO-SUMATRIPTAN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Post Market |
| 02271125 | RIVA-SUMATRIPTAN | LABORATOIRE RIVA INC. | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Post Market |
| 02271117 | RIVA-SUMATRIPTAN | LABORATOIRE RIVA INC. | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Post Market |
| 02271109 | RIVA-SUMATRIPTAN | LABORATOIRE RIVA INC. | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled Pre Market |
| 02263033 | SANDOZ SUMATRIPTAN | SANDOZ CANADA INCORPORATED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Post Market |
| 02263025 | SANDOZ SUMATRIPTAN | SANDOZ CANADA INCORPORATED | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Post Market |
| 02286513 | SUMATRIPTAN | SANIS HEALTH INC | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled Post Market |
| 02344734 | SUMATRIPTAN | COBALT PHARMACEUTICALS COMPANY | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 100 MG | Cancelled Pre Market |
| 02344726 | SUMATRIPTAN | COBALT PHARMACEUTICALS COMPANY | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 50 MG | Cancelled Pre Market |
| 02344718 | SUMATRIPTAN | COBALT PHARMACEUTICALS COMPANY | Tablet | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) 25 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 12470 | 2011-06-28 | Abbreviated New Drug Submission (ANDS) | Manufacturer and product name change |
| 10458 | 2009-07-31 | Supplement to an Abbreviated New Drug Submission (SANDS) | New dosage form |